The pharmaceutical giant Astra Zeneca reports a profit per share for the core business of 2.09 dollars, which can be compared to 1.45 dollars for the same period last year. The result was slightly better than the analysts' expectations, which were at a profit of 2.06 dollars per share, according to Bloomberg's compilation.
The revenues simultaneously amounted to 14.89 billion dollars. Here, the expectations according to Bloomberg were on average 14.21 billion dollars.
The board proposes a dividend to shareholders of 2.10 dollars per share. Together with an earlier dividend, the total dividend for the financial year will thus be 3.10 dollars.
